test

Kevin Tang

@Tang Capital Management Llc

Latest period2024 - Q3ReportedManaged Assets$1.4BTotal holdings154
Assets growth rate42.57%Assets growth rate (2-Q avg)22.41%Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Tang Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 154 positions.

Assets under management

The assets under management (AUM) of Tang Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.4B in assets, with a quarterly growth rate of 42.57% and a 2-quarter average growth rate of 22.41%. The portfolio is managed by Kevin Tang, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
DVAXDynavax Technologies Corp
Recent Activity
Decreased -24%
1.52%
$21.166M
1.9M shares@ $11.14 avg price
CRSPCrispr Therapeutics Ag
Recent Activity
Decreased -15.79%
0.9%
$12.52M
266,500 shares@ $46.98 avg price
OTLKOutlook Therapeutics Inc
Recent Activity
Decreased -3.69%
0.6%
$8.328M
1.56M shares@ $5.34 avg price
MRNSMarinus Pharmaceuticals Inc
Recent Activity
Decreased -2.08%
0.6%
$8.272M
4.7M shares@ $1.76 avg price
BDTXBlack Diamond Therapeutics I
Recent Activity
Decreased -14.53%
0.43%
$5.96M
1.37M shares@ $4.35 avg price
RPHMReneo Pharmaceuticals Inc
Recent Activity
Decreased -1.66%
0.36%
$5.009M
2.946M shares@ $1.7 avg price
BEAMBeam Therapeutics Inc
Recent Activity
Decreased -37.03%
0.3%
$4.165M
170,000 shares@ $24.5 avg price
BCABBioatla Inc
Recent Activity
Decreased -36.38%
0.11%
$1.538M
874,076 shares@ $1.77 avg price
ERASErasca Inc
Recent Activity
Decreased -8.56%
0.1%
$1.373M
502,915 shares@ $2.74 avg price
ENTAEnanta Pharmaceuticals Inc
Recent Activity
Decreased -57.78%
0.1%
$1.312M
126,655 shares@ $10.37 avg price